title: Chaperones as potential therapeutics for Krabbe disease.
abstract: Krabbe's disease (KD) is an autosomal recessive, neurodegenerative disorder. It is classified among the lysosomal storage diseases (LSDs). It was first described in , but the genetic defect for the galactocerebrosidase (GALC) gene was not discovered until the beginning of the 1970s, 20 years before the GALC cloning. Recently, in 2011, the crystal structures of the GALC enzyme and the GALC-product complex were obtained. For this, compared with other LSDs, the research on possible therapeutic interventions is much more recent. Thus, it is not surprising that some treatment options are still under preclinical investigation, whereas their relevance for other pathologies of the same group has already been tested in clinical studies. This is specifically the case for pharmacological chaperone therapy (PCT), a promising strategy for selectively correcting defective protein folding and trafficking and for enhancing enzyme activity by small molecules. These compounds bind directly to a partially folded biosynthetic intermediate, stabilize the protein, and allow completion of the folding process to yield a functional protein. Here, we review the chaperones that have demonstrated potential therapeutics during preclinical studies for KD, underscoring the requirement to invigorate research for KD-addressed PCT that will benefit from recent insights into the molecular understanding of GALC structure, drug design, and development in cellular models. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Department of Biomedical and Biotechnological Science, Section of Physiology, University of Catania, Catania, Italy.
authors.forename: Adriana Carol Eleonora
authors.initials: AC
authors.lastname: Graziano
authors.affiliation: Department of Biomedical and Biotechnological Science, Section of Physiology, University of Catania, Catania, Italy.
authors.forename: Giovanna
authors.initials: G
authors.lastname: Pannuzzo
authors.affiliation: Department of Biomedical and Biotechnological Science, Section of Physiology, University of Catania, Catania, Italy.
authors.forename: Rosanna
authors.initials: R
authors.lastname: Avola
authors.affiliation: Department of Biomedical and Biotechnological Science, Section of Physiology, University of Catania, Catania, Italy. cardile@unict.it.
authors.forename: Venera
authors.initials: V
authors.lastname: Cardile
mesh_terms: D000818:Animals; D006801:Humans; D007965:Leukodystrophy, Globoid Cell / Q000188:drug therapy*; D018832:Molecular Chaperones / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D018832:Molecular Chaperones
keywords: chaperone therapy; galactocerebrosidase; globoid cell leukodystrophy; lysosomal storage diseases; protein misprocessing